Study guide

BCOP study guide

Read a lesson, then practice the ideas you want to remember.

Lessons

  1. BCOP Exam Specifications, Passing Standard &
  2. The Clinical Oncology Pharmacist Scope of Pr
  3. Study Guide Methodology & Active Learning St
  4. Early-Stage & Locoregional Breast Cancer
  5. Advanced & Metastatic Breast Cancer Targeted
  6. Epithelial Ovarian, Endometrial & Cervical M
  7. Cell Cycle Checkpoints, Apoptotic Pathways &
  8. Hallmarks of Cancer, Multi-Step Carcinogenes
  9. Tumor Immunology, Antigen Presentation & Mec
  10. Regimen Standardization, Dose Calculation Fo
  11. Independent Double-Check, Verification Check
  12. Oral Chemotherapy Management, Adherence & Sp
  13. Oncology Clinical Trial Designs, Endpoints &
  14. Evidence Synthesis, Guideline Hierarchy & Cr
  15. Biostatistical Concepts: Hazard Ratios, Surv
  16. Alkylating Agents & Platinum Analogs — Free Study Guide 2026
  17. Antimetabolites & Folate Antagonists — Free Study Guide 2026
  18. Antimicrotubule Agents: Taxanes, Vinca Alkal
  19. Topoisomerase Inhibitors, Anthracyclines & C
  20. Cancer Screening, Early Detection & Preventi
  21. Performance Status Scales & Organ Function A
  22. TNM Staging Systems, Histopathologic Grading
  23. Circulating Tumor Markers, Flow Cytometry &
  24. Actionable Oncogenic Driver Mutations & Targ
  25. Pharmacogenomics in Oncology: DPYD, TPMT, NU
  26. Somatic vs Germline Mutations, NGS Profiling
  27. Colorectal Cancer: Staging, Adjuvant Therapy
  28. Esophagogastric, Pancreatic, and Hepatobilia
  29. Genitourinary Malignancies: Prostate, Renal
  30. Engineering Controls, Personal Protective Eq
  31. Safe Handling, Surface Decontamination & Acc
  32. USP <800> & NIOSH Hazardous Drug Standards
  33. Complementary, Alternative & Integrative The
  34. Oncology Formulary Management, Biosimilars &
  35. Patient & Caregiver Counseling, Survivorship
  36. Regulatory Mandates, REMS Programs & Investi
  37. Chimeric Antigen Receptor T-Cell Therapies &
  38. Immune Checkpoint Inhibitors & irAE Manageme
  39. Naked Monoclonal Antibodies, Antibody-Drug C
  40. Acute Myeloid & Acute Lymphoblastic Leukemia
  41. Chronic Leukemias & Myeloproliferative Neopl
  42. Multiple Myeloma & Plasma Cell Dyscrasias
  43. Non-Malignant Hematologic Disorders: ITP, Ap
  44. Hematopoietic Stem Cell Transplantation, Com
  45. Classical Hodgkin Lymphoma: Staging, Frontli
  46. Non-Hodgkin Lymphomas: Aggressive, Indolent,
  47. Chemotherapy-Induced Nausea and Vomiting Pro
  48. Chemotherapy Extravasation, Organ Protectant
  49. Myelosuppression, Febrile Neutropenia & Grow
  50. Oncologic Emergencies: TLS, Hypercalcemia, S
  51. Hematologic Small-Molecule Kinase Inhibitors
  52. Pathway-Specific Inhibitors: PARP, CDK4/6, B
  53. Small-Molecule Tyrosine Kinase Inhibitors in
  54. Cutaneous Melanoma & Non-Melanoma Skin Cance
  55. Early & Locally Advanced NSCLC & Small Cell
  56. Metastatic Non-Small Cell Lung Cancer — Free Study Guide 2026